p. 107−109
2476-762X
Vol.6/No.2
p. 110−112
2476-762X
Vol.6/No.2
p. 113−117
2476-762X
Vol.6/No.2
p. 118−122
2476-762X
Vol.6/No.2
p. 123−124
2476-762X
Vol.6/No.2
p. 125−129
2476-762X
Vol.6/No.2
p. 130−134
2476-762X
Vol.6/No.2
p. 135−138
2476-762X
Vol.6/No.2
p. 139−142
2476-762X
Vol.6/No.2
p. 143−146
2476-762X
Vol.6/No.2
p. 147−152
2476-762X
Vol.6/No.2
p. 153−158
2476-762X
Vol.6/No.2
p. 159−164
2476-762X
Vol.6/No.2
p. 165−169
2476-762X
Vol.6/No.2
p. 170−176
2476-762X
Vol.6/No.2
p. 177−180
2476-762X
Vol.6/No.2
p. 181−188
2476-762X
Vol.6/No.2
p. 189−194
2476-762X
Vol.6/No.2
p. 195−196
2476-762X
Vol.6/No.2
p. 197−201
2476-762X
Vol.6/No.2
p. 202−207
2476-762X
Vol.6/No.2
p. 208−212
2476-762X
Vol.6/No.2
0.05). Therefore, hepatitis B infection does not appear to be a contributing factor for hepatoblastoma. Further studies are needed to clarify which are the risk factors for the hepatoblastoma.]]>
p. 213−214
2476-762X
Vol.6/No.2
p. 215−216
2476-762X
Vol.6/No.2
p. 217−218
2476-762X
Vol.6/No.2
p. 219−220
2476-762X
Vol.6/No.2
p. 221−223
2476-762X
Vol.6/No.2
p. 224−230
2476-762X
Vol.6/No.2
p. 231−234
2476-762X
Vol.6/No.2